Aroa Historical Balance Sheet

ARX Stock

0.80 0.05 6.67%

Trend analysis of Aroa Biosurgery balance sheet accounts such as Other Current Liab of 5 M, Total Current Liabilities of 8.1 M or Total Stockholder Equity of 105.1 M provides information on Aroa Biosurgery's total assets, liabilities, and equity, which is the actual value of Aroa Biosurgery to its prevalent stockholders. By breaking down trends over time using Aroa Biosurgery balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Aroa Biosurgery latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Aroa Biosurgery is a good buy for the upcoming year.

Aroa Biosurgery Inventory

8.97 Million

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aroa Biosurgery. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About Aroa Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Aroa Biosurgery at a specified time, usually calculated after every quarter, six months, or one year. Aroa Biosurgery Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Aroa Biosurgery and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Aroa currently owns. An asset can also be divided into two categories, current and non-current.

Aroa Biosurgery Balance Sheet Chart

At this time, Aroa Biosurgery's Short and Long Term Debt Total is comparatively stable compared to the past year. Non Currrent Assets Other is likely to gain to about 109.6 K in 2025, whereas Accounts Payable is likely to drop slightly above 853.8 K in 2025.

Total Assets Other Current Liab Total Current Liabilities Total Stockholder Equity

Add Fundamental

Total Assets

Total assets refers to the total amount of Aroa Biosurgery assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Aroa Biosurgery books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Aroa Biosurgery balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Aroa Biosurgery are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Most accounts from Aroa Biosurgery's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Aroa Biosurgery current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aroa Biosurgery. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

	2022	2023	2024	2025 (projected)
Other Current Liabilities	5.1M	6.2M	5.6M	5.0M
Total Assets	109.1M	101.9M	117.2M	123.0M

Other Current Liab Total Assets

Aroa Biosurgery balance sheet Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Accounts Payable	Cash	Other Assets	Net Receivables	Short Term Investments	Other Current Assets	Total Liab	Common Stock	Property Plant Equipment	Net Tangible Assets	Retained Earnings	Other Stockholder Equity	Total Current Assets	Intangible Assets	Short Long Term Debt Total	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments
Total Assets		0.59	0.62	0.99	-0.2	0.7	0.43	-0.58	0.92	0.77	0.73	0.6	0.1	0.87	0.86	0.65	-0.91	0.99	0.33	0.71	0.9	-0.93	-0.27	0.95	0.94	0.91
Other Current Liab	0.59		0.87	0.5	-0.21	0.83	0.31	-0.75	0.54	0.4	0.4	0.76	-0.48	0.45	0.45	0.48	-0.55	0.54	0.12	0.33	0.52	-0.63	-0.11	0.63	0.62	0.44
Total Current Liabilities	0.62	0.87		0.53	-0.18	0.72	0.57	-0.55	0.49	0.31	0.35	0.79	-0.46	0.49	0.45	0.56	-0.64	0.58	0.13	0.63	0.52	-0.7	-0.37	0.65	0.7	0.54
Total Stockholder Equity	0.99	0.5	0.53		-0.24	0.66	0.37	-0.49	0.92	0.81	0.73	0.47	0.24	0.89	0.9	0.55	-0.86	0.99	0.27	0.68	0.91	-0.88	-0.21	0.92	0.9	0.91
Other Liab	-0.2	-0.21	-0.18	-0.24		-0.05	-0.13	-0.26	-0.14	-0.16	-0.08	0.08	-0.52	-0.17	-0.19	0.36	-0.1	-0.17	0.29	-0.19	-0.19	0.25	0.1	-0.24	-0.25	-0.21
Accounts Payable	0.7	0.83	0.72	0.66	-0.05		0.37	-0.68	0.59	0.6	0.68	0.56	-0.24	0.67	0.59	0.48	-0.66	0.7	0.11	0.44	0.71	-0.61	-0.14	0.67	0.62	0.65
Cash	0.43	0.31	0.57	0.37	-0.13	0.37		-0.25	0.18	-0.04	0.32	0.58	-0.2	0.26	0.02	0.48	-0.52	0.44	0.22	0.9	0.24	-0.56	-0.96	0.44	0.57	0.57
Other Assets	-0.58	-0.75	-0.55	-0.49	-0.26	-0.68	-0.25		-0.61	-0.4	-0.3	-0.73	0.56	-0.35	-0.37	-0.68	0.68	-0.55	-0.41	-0.27	-0.43	0.57	0.14	-0.57	-0.56	-0.44
Net Receivables	0.92	0.54	0.49	0.92	-0.14	0.59	0.18	-0.61		0.69	0.57	0.45	0.15	0.8	0.91	0.51	-0.78	0.9	0.29	0.5	0.88	-0.79	-0.04	0.87	0.8	0.7
Short Term Investments	0.77	0.4	0.31	0.81	-0.16	0.6	-0.04	-0.4	0.69		0.58	0.23	0.26	0.77	0.83	0.4	-0.69	0.81	0.12	0.28	0.74	-0.64	0.21	0.68	0.65	0.79
Other Current Assets	0.73	0.4	0.35	0.73	-0.08	0.68	0.32	-0.3	0.57	0.58		0.41	0.11	0.76	0.59	0.49	-0.62	0.74	0.26	0.5	0.72	-0.65	-0.21	0.7	0.66	0.68
Total Liab	0.6	0.76	0.79	0.47	0.08	0.56	0.58	-0.73	0.45	0.23	0.41		-0.64	0.42	0.24	0.88	-0.75	0.55	0.47	0.58	0.41	-0.78	-0.48	0.69	0.76	0.51
Common Stock	0.1	-0.48	-0.46	0.24	-0.52	-0.24	-0.2	0.56	0.15	0.26	0.11	-0.64		0.28	0.31	-0.49	0.17	0.14	-0.24	0.0	0.27	0.05	0.17	0.06	-0.03	0.14
Property Plant Equipment	0.87	0.45	0.49	0.89	-0.17	0.67	0.26	-0.35	0.8	0.77	0.76	0.42	0.28		0.85	0.54	-0.78	0.88	0.27	0.56	0.97	-0.8	-0.08	0.9	0.81	0.79
Net Tangible Assets	0.86	0.45	0.45	0.9	-0.19	0.59	0.02	-0.37	0.91	0.83	0.59	0.24	0.31	0.85		0.34	-0.69	0.86	0.11	0.41	0.9	-0.68	0.17	0.78	0.7	0.71
Retained Earnings	0.65	0.48	0.56	0.55	0.36	0.48	0.48	-0.68	0.51	0.4	0.49	0.88	-0.49	0.54	0.34		-0.87	0.64	0.6	0.57	0.49	-0.77	-0.4	0.7	0.77	0.62
Other Stockholder Equity	-0.91	-0.55	-0.64	-0.86	-0.1	-0.66	-0.52	0.68	-0.78	-0.69	-0.62	-0.75	0.17	-0.78	-0.69	-0.87		-0.92	-0.43	-0.73	-0.76	0.92	0.37	-0.88	-0.92	-0.89
Total Current Assets	0.99	0.54	0.58	0.99	-0.17	0.7	0.44	-0.55	0.9	0.81	0.74	0.55	0.14	0.88	0.86	0.64	-0.92		0.32	0.72	0.89	-0.91	-0.28	0.93	0.93	0.94
Intangible Assets	0.33	0.12	0.13	0.27	0.29	0.11	0.22	-0.41	0.29	0.12	0.26	0.47	-0.24	0.27	0.11	0.6	-0.43	0.32		0.3	0.24	-0.42	-0.28	0.39	0.41	0.28
Short Long Term Debt Total	0.71	0.33	0.63	0.68	-0.19	0.44	0.9	-0.27	0.5	0.28	0.5	0.58	0.0	0.56	0.41	0.57	-0.73	0.72	0.3		0.54	-0.77	-0.82	0.69	0.79	0.8
Property Plant And Equipment Net	0.9	0.52	0.52	0.91	-0.19	0.71	0.24	-0.43	0.88	0.74	0.72	0.41	0.27	0.97	0.9	0.49	-0.76	0.89	0.24	0.54		-0.79	-0.05	0.92	0.8	0.75
Current Deferred Revenue	-0.93	-0.63	-0.7	-0.88	0.25	-0.61	-0.56	0.57	-0.79	-0.64	-0.65	-0.78	0.05	-0.8	-0.68	-0.77	0.92	-0.91	-0.42	-0.77	-0.79		0.43	-0.96	-1.0	-0.87
Net Debt	-0.27	-0.11	-0.37	-0.21	0.1	-0.14	-0.96	0.14	-0.04	0.21	-0.21	-0.48	0.17	-0.08	0.17	-0.4	0.37	-0.28	-0.28	-0.82	-0.05	0.43		-0.29	-0.43	-0.42
Non Current Assets Total	0.95	0.63	0.65	0.92	-0.24	0.67	0.44	-0.57	0.87	0.68	0.7	0.69	0.06	0.9	0.78	0.7	-0.88	0.93	0.39	0.69	0.92	-0.96	-0.29		0.96	0.83
Non Currrent Assets Other	0.94	0.62	0.7	0.9	-0.25	0.62	0.57	-0.56	0.8	0.65	0.66	0.76	-0.03	0.81	0.7	0.77	-0.92	0.93	0.41	0.79	0.8	-1.0	-0.43	0.96		0.89
Cash And Short Term Investments	0.91	0.44	0.54	0.91	-0.21	0.65	0.57	-0.44	0.7	0.79	0.68	0.51	0.14	0.79	0.71	0.62	-0.89	0.94	0.28	0.8	0.75	-0.87	-0.42	0.83	0.89

Click cells to compare fundamentals

Aroa Biosurgery Account Relationship Matchups

Aroa Biosurgery balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	73.1M	104.7M	109.1M	101.9M	117.2M	123.0M
Other Current Liab	3.7M	4.5M	5.1M	6.2M	5.6M	5.0M
Total Current Liabilities	14.0M	6.2M	7.4M	8.7M	7.9M	8.1M
Total Stockholder Equity	53.7M	93.4M	95.4M	87.1M	100.1M	105.1M
Other Liab	154K	158K	161K	164K	147.6K	140.2K
Accounts Payable	679.3K	1.2M	1.8M	1.6M	1.4M	853.8K
Cash	32.5M	5.7M	8.9M	10.6M	12.2M	8.2M
Net Receivables	6.6M	16.0M	13.4M	24.1M	27.7M	29.1M
Short Term Investments	1.5M	47.6M	34.1M	17.2M	19.7M	20.7M
Other Current Assets	907.0K	1.2M	10.4M	4.1M	3.7M	3.6M
Total Liab	19.4M	11.3M	13.7M	14.8M	13.3M	13.8M
Common Stock	89.3M	135.5M	137.1M	134.6M	154.8M	108.9M
Property Plant Equipment	8.7M	12.7M	15.4M	20.6M	18.6M	10.5M
Net Tangible Assets	(11.5M)	40.4M	83.2M	85.6M	98.4M	103.4M
Retained Earnings	(39.2M)	(47.5M)	(48.2M)	(57.0M)	(65.5M)	(68.8M)
Other Stockholder Equity	(0.22)	(489.4K)	(0.03)	(24.8K)	(22.4K)	(21.2K)
Total Current Assets	44.8M	74.2M	73.1M	63.3M	72.8M	76.5M
Intangible Assets	11.5M	10.9M	11.3M	13.0M	14.9M	12.6M
Short Long Term Debt Total	15.4M	5.8M	7.1M	6.8M	7.8M	8.2M
Property Plant And Equipment Net	11.6M	14.3M	19.3M	20.4M	23.4M	13.4M
Net Debt	(17.6M)	(268.6K)	(2.3M)	(3.7M)	(4.3M)	(4.5M)
Non Current Assets Total	28.4M	30.5M	35.9M	38.5M	44.3M	30.1M
Non Currrent Assets Other	157.0K	138.5K	117.9K	90.8K	104.4K	109.6K
Cash And Short Term Investments	33.9M	53.4M	43.0M	27.7M	31.9M	32.7M
Good Will	5.1M	5.1M	5.2M	5.1M	4.6M	4.2M
Common Stock Shares Outstanding	300.4M	342.2M	342.9M	343.8M	395.4M	350.4M
Long Term Debt Total	3.0M	5.7M	5.3M	6.5M	7.5M	4.1M
Liabilities And Stockholders Equity	73.1M	104.7M	109.1M	101.9M	117.2M	82.3M
Non Current Liabilities Total	5.4M	5.1M	6.3M	6.1M	5.5M	7.5M
Inventory	3.3M	3.7M	4.5M	7.4M	8.5M	9.0M
Accumulated Other Comprehensive Income	3.6M	5.5M	6.5M	9.4M	10.9M	11.4M
Short Term Debt	9.7M	547.4K	523.3K	920.9K	1.1M	1.0M
Capital Lease Obligations	5.8M	5.5M	6.7M	6.8M	7.8M	5.9M
Net Invested Capital	62.8M	93.4M	95.4M	87.1M	100.2M	91.1M
Property Plant And Equipment Gross	17.3M	20.8M	27.6M	30.5M	35.1M	23.0M
Capital Stock	89.3M	135.5M	137.1M	134.7M	154.9M	130.0M
Net Working Capital	30.7M	68.0M	65.7M	54.6M	62.8M	59.0M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Aroa Stock Analysis

When running Aroa Biosurgery's price analysis, check to measure Aroa Biosurgery's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aroa Biosurgery is operating at the current time. Most of Aroa Biosurgery's value examination focuses on studying past and present price action to predict the probability of Aroa Biosurgery's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aroa Biosurgery's price. Additionally, you may evaluate how the addition of Aroa Biosurgery to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC